{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:22:07Z","timestamp":1787865727878,"version":"build-2784847793"},"reference-count":91,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["09150172310053"],"award-info":[{"award-number":["09150172310053"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["03-004-2021-T045"],"award-info":[{"award-number":["03-004-2021-T045"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101076407"],"award-info":[{"award-number":["101076407"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.atherosclerosis.2026.121865","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:36:11Z","timestamp":1785911771000},"page":"121865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development"],"prefix":"10.1016","volume":"420","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8954-1337","authenticated-orcid":false,"given":"Kang H.","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie L.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.G.","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.121865_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"issue":"25 Pt A","key":"10.1016\/j.atherosclerosis.2026.121865_bib2","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2014.04.018","article-title":"The prevalence, incidence, progression, and risks of aortic valve sclerosis: a systematic review and meta-analysis","volume":"63","author":"Coffey","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.121865_bib3","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1136\/heartjnl-2021-319025","article-title":"Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults","volume":"107","author":"Owens","year":"2021","journal-title":"Heart"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib4","article-title":"Transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years","author":"Leon","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131996","article-title":"Patterns of aortic valve replacement in Europe and adoption by sex","volume":"406","author":"Bleiziffer","year":"2024","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121865_bib6","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jacc.2022.05.006","article-title":"Evolution and prognostic impact of cardiac damage after aortic valve replacement","volume":"80","author":"Genereux","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib7","first-page":"1","article-title":"Pathophysiology of aortic stenosis and future perspectives for medical therapy","volume":"38","author":"Zheng","year":"2020","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib8","article-title":"Genomic and transcriptomic analyses of aortic stenosis enhance therapeutic target discovery and disease prediction","author":"Small","year":"2025","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121865_bib9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/CIRCULATIONAHA.122.061451","article-title":"Multiancestry genome-wide association study of aortic stenosis identifies multiple novel loci in the Million veteran program","volume":"147","author":"Small","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib10","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/s41467-024-46639-4","article-title":"Integrative genomic analyses identify candidate causal genes for calcific aortic valve stenosis involving tissue-specific regulation","volume":"15","author":"Theriault","year":"2024","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.121865_bib11","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/eurheartj\/ehad142","article-title":"Dyslipidemia, inflammation, calcification, and adiposity in aortic stenosis: a genome-wide study","volume":"44","author":"Yu Chen","year":"2023","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib12","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41467-018-03260-6","article-title":"A transcriptome-wide association study identifies PALMD as a susceptibility gene for calcific aortic valve stenosis","volume":"9","author":"Theriault","year":"2018","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121865_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102241","article-title":"Enhancer-associated aortic valve stenosis risk locus 1p21.2 alters NFATC2 binding site and promotes fibrogenesis","volume":"24","author":"Chignon","year":"2021","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121865_bib14","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jacbts.2023.06.004","article-title":"Palmdelphin deficiency evokes NF-kappaB signaling in valvular endothelial cells and aggravates aortic valvular remodeling","volume":"8","author":"Han","year":"2023","journal-title":"JACC, Basic Transl Sci"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121865_bib15","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.121.054182","article-title":"Palmdelphin regulates nuclear resilience to mechanical stress in the endothelium","volume":"144","author":"Sainz-Jaspeado","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.101887","article-title":"PALMD regulates aortic valve calcification via altered glycolysis and NF-\u03baB-mediated inflammation","volume":"298","author":"Wang","year":"2022","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121865_bib17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/CIRCRESAHA.120.317979","article-title":"Multi-Omics approaches to define calcific aortic valve disease pathogenesis","volume":"128","author":"Blaser","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib18","article-title":"Advances in single-cell transcriptomics: unraveling the pathogenesis of calcific aortic valve disease","author":"Qin","year":"2025","journal-title":"Cardiovasc Res"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121865_bib19","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1161\/ATVBAHA.120.314789","article-title":"Cell-type transcriptome atlas of human aortic valves reveal cell heterogeneity and endothelial to mesenchymal transition involved in calcific aortic valve disease","volume":"40","author":"Xu","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121865_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110685","article-title":"A disease-driver population within interstitial cells of human calcific aortic valves identified via single-cell and proteomic profiling","volume":"39","author":"Decano","year":"2022","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121865_bib21","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/eurheartj\/ehac818","article-title":"Sortilin enhances fibrosis and calcification in aortic valve disease by inducing interstitial cell heterogeneity","volume":"44","author":"Iqbal","year":"2023","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCULATIONAHA.123.066822","article-title":"Major facilitator superfamily domain containing 5 inhibition reduces lipoprotein(a) uptake and calcification in valvular heart disease","volume":"149","author":"Rogers","year":"2024","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.atherosclerosis.2026.121865_bib23","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1093\/eurheartj\/ehae407","article-title":"Lumican promotes calcific aortic valve disease through H3 histone lactylation","volume":"45","author":"Huang","year":"2024","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121865_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeaf068","article-title":"Fuelling aortic stenosis: the integral role of 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3-mediated glycolysis in Lp(a)-induced valve inflammation","volume":"5","author":"Peletier","year":"2025","journal-title":"Eur Heart J Open"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.121865_bib25","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/CIRCULATIONAHA.124.071954","article-title":"Aortic valve calcification is induced by the loss of ALDH1A1 and can be prevented by agonists of retinoic acid receptor alpha: preclinical evidence for drug repositioning","volume":"151","author":"Rosa","year":"2025","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.121865_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188562","article-title":"Epigenetic dysregulation of energy homeostasis drives aortic valve stenosis that is treatable with metformin","volume":"10","author":"Cashman","year":"2025","journal-title":"JCI Insight"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121865_bib27","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/CIRCULATIONAHA.123.065213","article-title":"AVCAPIR: a novel procalcific PIWI-interacting RNA in calcific aortic valve disease","volume":"149","author":"Han","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib28","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/cvr\/cvae253","article-title":"The N6-methyladenosine demethylase ALKBH5 is a novel epigenetic regulator of aortic valve calcification","volume":"121","author":"Wang","year":"2025","journal-title":"Cardiovasc Res"},{"issue":"30","key":"10.1016\/j.atherosclerosis.2026.121865_bib29","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1093\/eurheartj\/ehab316","article-title":"DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells","volume":"42","author":"Wang","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib30","first-page":"983","article-title":"Therapeutic inhibition of microRNA-34a ameliorates aortic valve calcification via modulation of Notch1-Runx2 signalling","volume":"116","author":"Toshima","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe3706","article-title":"Nitric oxide prevents aortic valve calcification by S-nitrosylation of USP9X to activate NOTCH signaling","volume":"7","author":"Majumdar","year":"2021","journal-title":"Sci Adv"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121865_bib32","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.122.063481","article-title":"Toll-like receptor 3 mediates aortic stenosis through a conserved mechanism of calcification","volume":"147","author":"Gollmann-Tepekoylu","year":"2023","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121865_bib33","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1093\/cvr\/cvad117","article-title":"Aortic valve calcification is promoted by interleukin-8 and restricted through antagonizing CXC motif chemokine receptor 2","volume":"119","author":"Dhayni","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib34","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jacc.2023.11.021","article-title":"Large-scale proteomics identifies novel biomarkers and circulating risk factors for aortic stenosis","volume":"83","author":"Shelbaya","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121865_bib35","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.122.063402","article-title":"Multiomics of tissue extracellular vesicles identifies unique modulators of atherosclerosis and calcific aortic valve stenosis","volume":"148","author":"Blaser","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.778919","article-title":"Lipoprotein(a) induces vesicular cardiovascular calcification revealed with single-extracellular vesicle analysis","volume":"9","author":"Rogers","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121865_bib37","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.jacbts.2023.04.010","article-title":"Negative impact of TET2 mutations on long-term survival after transcatheter aortic valve replacement","volume":"8","author":"Lassalle","year":"2023","journal-title":"JACC, Basic Transl Sci"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121865_bib38","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/eurheartj\/ehz591","article-title":"Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation","volume":"41","author":"Mas-Peiro","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121865_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101532","article-title":"Clonal hematopoiesis is associated with adverse clinical outcomes and left ventricular remodeling in aortic stenosis","volume":"4","author":"Yao","year":"2025","journal-title":"JACC Adv"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.121865_bib40","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/jamacardio.2020.2468","article-title":"Association of clonal hematopoiesis of indeterminate potential with inflammatory gene expression in patients with severe degenerative aortic valve stenosis or chronic postischemic heart failure","volume":"5","author":"Abplanalp","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib41","article-title":"Clonal hematopoiesis activates pro-calcific pathways in macrophages and promotes aortic valve stenosis","author":"Abplanalp","year":"2025","journal-title":"J Clin Investig"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib42","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/jamacardio.2022.0386","article-title":"TET2-Driven clonal hematopoiesis and response to canakinumab: an exploratory analysis of the CANTOS randomized clinical trial","volume":"7","author":"Svensson","year":"2022","journal-title":"JAMA Cardiol"},{"issue":"21","key":"10.1016\/j.atherosclerosis.2026.121865_bib43","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.jacc.2025.08.025","article-title":"Colchicine and longitudinal dynamics of clonal hematopoiesis: an exploratory substudy of the LoDoCo2 trial","volume":"86","author":"Mohammadnia","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.atherosclerosis.2016.01.023","article-title":"The effect of statins on valve function and calcification in aortic stenosis: a meta-analysis","volume":"246","author":"Zhao","year":"2016","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121865_bib45","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.amjcard.2019.08.037","article-title":"Relation of lipid-lowering therapy to need for aortic valve replacement in patients with asymptomatic mild to moderate aortic stenosis","volume":"124","author":"Greve","year":"2019","journal-title":"Am J Cardiol"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121865_bib46","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121865_bib47","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1016\/j.jtcvs.2019.10.081","article-title":"Simvastatin down-regulates osteogenic response in cultured human aortic valve interstitial cells","volume":"161","author":"Jarrett","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121865_bib48","doi-asserted-by":"crossref","first-page":"H903","DOI":"10.1152\/ajpheart.00263.2012","article-title":"A time course investigation of the statin paradox among valvular interstitial cell phenotypes","volume":"303","author":"Monzack","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121865_bib49","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/01.ATV.0000154278.01871.64","article-title":"Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease","volume":"25","author":"Wu","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.121865_bib50","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/CIRCULATIONAHA.123.067537","article-title":"Atorvastatin effect on aortic dilatation and valvular calcification progression in bicuspid aortic valve (BICATOR): a randomized clinical trial","volume":"149","author":"Evangelista","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121865_bib51","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1210\/jc.2016-1206","article-title":"PCSK9 R46L loss-of-function mutation reduces Lipoprotein(a), LDL cholesterol, and risk of aortic valve stenosis","volume":"101","author":"Langsted","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.121865_bib52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jacbts.2020.05.004","article-title":"Genetic and in vitro inhibition of PCSK9 and calcific aortic valve stenosis","volume":"5","author":"Perrot","year":"2020","journal-title":"JACC, Basic Transl Sci"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121865_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101549","article-title":"Impact of proprotein convertase Subtilisin\/Kexin type 9 inhibitors on Lipoprotein(a): a meta-analysis and meta-regression of randomized controlled trials","volume":"4","author":"Rivera","year":"2025","journal-title":"JACC Adv"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib54","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/joim.13457","article-title":"PCSK9 inhibition with alirocumab decreases plasma lipoprotein(a) concentration by a dual mechanism of action in statin-treated patients with very high apolipoprotein(a) concentration","volume":"291","author":"Ying","year":"2022","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib55","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/jamacardio.2020.0728","article-title":"An exploratory analysis of proprotein convertase Subtilisin\/Kexin type 9 inhibition and aortic stenosis in the FOURIER trial","volume":"5","author":"Bergmark","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"19","key":"10.1016\/j.atherosclerosis.2026.121865_bib56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.042112","article-title":"Rationale and design of the EPISODE trial: a randomized controlled trial on the effect of PCSK9 inhibitors in calcific aortic valve stenosis","volume":"14","author":"Zheng","year":"2025","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121865_bib57","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/CIRCGENETICS.113.000400","article-title":"Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort","volume":"7","author":"Arsenault","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121865_bib58","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamacardio.2024.1882","article-title":"Lipoprotein(a) and calcific aortic valve stenosis progression: a systematic review and meta-analysis","volume":"9","author":"Arsenault","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121865_bib59","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jcmg.2022.09.007","article-title":"Lipoprotein(a) and aortic valve calcification: the multi-ethnic study of atherosclerosis","volume":"16","author":"Bhatia","year":"2023","journal-title":"JACC, Cardiovasc Imaging"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.121865_bib60","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1136\/heartjnl-2021-319044","article-title":"Lipoprotein(a) is robustly associated with aortic valve calcium","volume":"107","author":"Kaiser","year":"2021","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121865_bib61","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib62","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.121865_bib63","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2019.01.070","article-title":"Lipoprotein(a) and oxidized phospholipids promote valve calcification in patients with aortic stenosis","volume":"73","author":"Zheng","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121865_bib64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa1905239","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib65","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.124.069210","article-title":"Lipoprotein(a) as a pharmacological target: premises, promises, and prospects","volume":"151","author":"Greco","year":"2025","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib66","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/jamacardio.2020.0246","article-title":"Association of FADS1\/2 locus variants and polyunsaturated fatty acids with aortic stenosis","volume":"5","author":"Chen","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121865_bib67","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002710","article-title":"FADS1 (Fatty acid desaturase 1) genotype associates with aortic valve FADS mRNA expression, fatty acid content and calcification","volume":"13","author":"Plunde","year":"2020","journal-title":"Circ Genom Precis Med"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121865_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCULATIONAHA.119.041868","article-title":"Omega-3 polyunsaturated fatty acids decrease aortic valve disease through the resolvin E1 and ChemR23 axis","volume":"142","author":"Artiach","year":"2020","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib69","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44387-x","article-title":"The effect of immunomodulatory drugs on aortic stenosis: a Mendelian randomisation analysis","volume":"13","author":"Ciofani","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ahj.2025.07.010","article-title":"The effects of low-dose colchicine on the progression of aortic valve stenosis: rationale, design, and baseline characteristics of the Colchicine and Inflammation in Aortic Stenosis (CHIANTI) trial","volume":"290","author":"Mohammadnia","year":"2025","journal-title":"Am Heart J"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.121865_bib72","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016911","article-title":"Renin-angiotensin System blockade in aortic stenosis: implications before and after aortic valve replacement","volume":"9","author":"Goel","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121865_bib73","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2006.11.043","article-title":"Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits","volume":"49","author":"Arishiro","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.121865_bib74","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/ehjci\/jev043","article-title":"A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial)","volume":"16","author":"Bull","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121865_bib75","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ahj.2013.11.002","article-title":"Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study","volume":"167","author":"Dalsgaard","year":"2014","journal-title":"Am Heart J"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121865_bib76","first-page":"1690","article-title":"Angiotensin II receptor blockers are associated with reduced valvular fibrosis in women with aortic stenosis","volume":"40","author":"Carter-Storch","year":"2024","journal-title":"Can J Cardiol"},{"issue":"20","key":"10.1016\/j.atherosclerosis.2026.121865_bib77","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1161\/CIRCULATIONAHA.116.024270","article-title":"Dipeptidyl Peptidase-4 induces aortic valve calcification by inhibiting insulin-like growth Factor-1 signaling in valvular interstitial cells","volume":"135","author":"Choi","year":"2017","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.121865_bib78","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/heartjnl-2020-317024","article-title":"Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis","volume":"106","author":"Lee","year":"2020","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121865_bib79","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.jacc.2024.06.037","article-title":"Effect of evogliptin on the progression of aortic valvular calcification","volume":"84","author":"Song","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib80","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s10020-021-00416-x","article-title":"Metformin alleviates the calcification of aortic valve interstitial cells through activating the PI3K\/AKT pathway in an AMPK dependent way","volume":"27","author":"En","year":"2021","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47774-6","article-title":"Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux","volume":"13","author":"Phadwal","year":"2023","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121865_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-31070-6","article-title":"Metformin mitigates aortic valve degeneration in an ex vivo three-dimensional tissue model","volume":"15","author":"Schoettler","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2026.121865_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.709741","article-title":"Decreased glucagon-like Peptide-1 is associated with calcific aortic valve disease: GLP-1 suppresses the calcification of aortic valve interstitial cells","volume":"8","author":"Xiao","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121865_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/jcdd10090386","article-title":"Liraglutide Attenuates aortic valve calcification in a high-cholesterol-diet-induced experimental calcific aortic valve disease model in apolipoprotein E-Deficient mice","volume":"10","author":"Zhou","year":"2023","journal-title":"J Cardiovasc Dev Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib85","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jcin.2024.11.036","article-title":"Effect of sodium-glucose Cotransporter-2 inhibitors on the progression of aortic stenosis","volume":"18","author":"Shah","year":"2025","journal-title":"JACC Cardiovasc Interv"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2026.121865_bib86","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","article-title":"Dapagliflozin in patients undergoing transcatheter aortic-valve implantation","volume":"392","author":"Raposeiras-Roubin","year":"2025","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.121865_bib87","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/CIRCULATIONAHA.123.066523","article-title":"Reactivation of oxidized soluble guanylate cyclase as a novel treatment strategy to slow progression of calcific aortic valve stenosis: preclinical and randomized clinical trials to assess safety and efficacy","volume":"151","author":"Zhang","year":"2025","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121865_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeaf144","article-title":"Testing if vitamin K1 reduces the progression of non-severe calcific aortic stenosis: design and rationale of the Prevention of Aortic Stenosis Progression Phylloquinone Ossification Reduction Trial (PASSPORT)","volume":"5","author":"Courtney","year":"2025","journal-title":"Eur Heart J Open"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2026.121865_bib89","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.121.057008","article-title":"Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial","volume":"145","author":"Diederichsen","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121865_bib90","doi-asserted-by":"crossref","DOI":"10.3390\/nu10040386","article-title":"Bicuspid aortic valve stenosis and the effect of vitamin K2 on calcification using (18)F-Sodium fluoride positron emission tomography\/magnetic resonance: the BASIK2 rationale and trial design","volume":"10","author":"Peeters","year":"2018","journal-title":"Nutrients"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.121865_bib91","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1161\/CIRCULATIONAHA.121.053708","article-title":"Effect of denosumab or alendronic acid on the progression of aortic stenosis: a double-blind randomized controlled trial","volume":"143","author":"Pawade","year":"2021","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T20:55:52Z","timestamp":1787864152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":91,"alternative-id":["S0021915026012311"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121865","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aortic valve stenosis in 2026: from emerging mechanisms to clinical drug development","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121865","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121865"}}